142 related articles for article (PubMed ID: 2693916)
1. Calcitonin and lumbar bone mineral content during oestrogen-progestogen administration in post-menopausal women.
Isaia G; Campagnoli C; Mussetta M; Massobrio M; Salamano G; Gallo M; Molinatti GM
Maturitas; 1989 Dec; 11(4):287-94. PubMed ID: 2693916
[TBL] [Abstract][Full Text] [Related]
2. Effect of hormone replacement therapy and calcitonin on bone mass in postmenopausal women.
Meschia M; Brincat M; Barbacini P; Maini MC; Marri R; Crosignani PG
Eur J Obstet Gynecol Reprod Biol; 1992 Oct; 47(1):53-7. PubMed ID: 1330761
[TBL] [Abstract][Full Text] [Related]
3. [Effect of suppletory estrogen or 1,25(OH)D3 on bone mineral content].
Amano K; Nemoto R; Kato Y; Masuda R; Nishijima M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jul; 44(7):833-6. PubMed ID: 1500805
[TBL] [Abstract][Full Text] [Related]
4. Medroxyprogesterone acetate enhances the spinal bone mineral density response to oestrogen in late post-menopausal women.
Grey A; Cundy T; Evans M; Reid I
Clin Endocrinol (Oxf); 1996 Mar; 44(3):293-6. PubMed ID: 8729524
[TBL] [Abstract][Full Text] [Related]
5. Osteoporosis prevention clinical study program.
Delmas P; Gimona A
Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S39-45. PubMed ID: 8732473
[TBL] [Abstract][Full Text] [Related]
6. Oestrogen-receptor-alpha gene polymorphism affects response in bone mineral density to oestrogen in post-menopausal women.
Ongphiphadhanakul B; Chanprasertyothin S; Payatikul P; Tung SS; Piaseu N; Chailurkit L; Chansirikarn S; Puavilai G; Rajatanavin R
Clin Endocrinol (Oxf); 2000 May; 52(5):581-5. PubMed ID: 10792337
[TBL] [Abstract][Full Text] [Related]
7. Effects on bone of oral hormone replacement therapy initiated 2 years after ovariectomy in young adult monkeys.
Jayo MJ; Register TC; Carlson CS
Bone; 1998 Oct; 23(4):361-6. PubMed ID: 9763148
[TBL] [Abstract][Full Text] [Related]
8. Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post-menopausal osteoporosis.
Grey AB; Cundy TF; Reid IR
Clin Endocrinol (Oxf); 1994 May; 40(5):671-7. PubMed ID: 8013147
[TBL] [Abstract][Full Text] [Related]
9. Effect of intranasal salmon calcitonin therapy on bone mass and bone turnover in early postmenopausal women: a dose-response study.
Overgaard K
Calcif Tissue Int; 1994 Aug; 55(2):82-6. PubMed ID: 7953984
[TBL] [Abstract][Full Text] [Related]
10. Pattern of bone loss in surgical menopause: a preliminary report.
Chittacharoen A; Theppisai U; Sirisriro R; Thanantaseth C
J Med Assoc Thai; 1997 Nov; 80(11):731-7. PubMed ID: 9385771
[TBL] [Abstract][Full Text] [Related]
11. Effects on bone of surgical menopause and estrogen therapy with or without progesterone replacement in cynomolgus monkeys.
Jayo MJ; Weaver DS; Adams MR; Rankin SE
Am J Obstet Gynecol; 1990 Aug; 163(2):614-8. PubMed ID: 2386153
[TBL] [Abstract][Full Text] [Related]
12. Soymilk or progesterone for prevention of bone loss--a 2 year randomized, placebo-controlled trial.
Lydeking-Olsen E; Beck-Jensen JE; Setchell KD; Holm-Jensen T
Eur J Nutr; 2004 Aug; 43(4):246-57. PubMed ID: 15309425
[TBL] [Abstract][Full Text] [Related]
13. Effect of oestrogen replacement therapy on bone mass in post-menopausal Bangladeshi women.
Begum F; Shamsuddin L; Hussain MA; Chowdhury TA; Rahman M; Das TR
Bangladesh Med Res Counc Bull; 2001 Dec; 27(3):103-11. PubMed ID: 12197624
[TBL] [Abstract][Full Text] [Related]
14. A clinical trial on the effects of a combination of elcatonin (carbocalcitonin) and conjugated estrogens on vertebral bone mass in early postmenopausal women.
Meschia M; Brincat M; Barbacini P; Crossignani PG; Albisetti W
Calcif Tissue Int; 1993 Jul; 53(1):17-20. PubMed ID: 8394192
[TBL] [Abstract][Full Text] [Related]
15. Effects of oestrogens and progestogens on coronary atherosclerosis and osteoporosis of monkeys.
Adams MR; Williams JK; Clarkson TB; Jayo MJ
Baillieres Clin Obstet Gynaecol; 1991 Dec; 5(4):915-34. PubMed ID: 1822826
[TBL] [Abstract][Full Text] [Related]
16. Estrogen-progestogen replacement therapy in postmenopausal women--is 1 mg estradiolvalerate sufficient to maintain axial trabecular bone density?
Dören M; Schneider HP
Int J Clin Pharmacol Ther; 1994 May; 32(5):254-8. PubMed ID: 7921520
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis.
van den Brink HR; Lems WF; van Everdingen AA; Bijlsma JW
Ann Rheum Dis; 1993 Apr; 52(4):302-5. PubMed ID: 8484698
[TBL] [Abstract][Full Text] [Related]
18. Effects of estrogen/androgen therapy on bone mineral density parameters.
Notelovitz M
J Reprod Med; 2001 Mar; 46(3 Suppl):325-31. PubMed ID: 11304880
[TBL] [Abstract][Full Text] [Related]
19. Prevention of bone loss by hormone replacement therapy is probably not due to stimulation of calcitonin secretion.
Fletcher CD; Farish E; Leggate J; Hart DM
Acta Endocrinol (Copenh); 1991 Apr; 124(4):353-6. PubMed ID: 2031433
[TBL] [Abstract][Full Text] [Related]
20. Use of progestogens in postmenopausal women.
Gambrell RD
Int J Fertil; 1989; 34(5):315-21. PubMed ID: 2571591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
